R-Tech Ueno - Crunchbase Company Profile & Funding

Start Free Trial

Overview

R-Tech Ueno

Growth Score

83

Heat Score

47

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About R-Tech Ueno

CB Rank

1110358

R-Tech Ueno is a Japanese pharmaceutical company that manufactures AMITIZA for Sucampo and Sucampo's commercialization partners.

Acquired by

Sucampo Pharmaceuticals

Founded

obfuscation

Private

Tokyo, Tokyo, Japan

Key People

Shuji Inoue: Executive chairman
Yukiko Hashidera: President & CEO

Details

Legal Name

R-Tech Ueno, Limited

Also Known As

R-Tech

Operating Status

Active

Company Type

For Profit

Founders

Ryuji Ueno, Sachiko Kuno

About the Company

R-Tech Ueno sells pharmaceuticals. It is a Japanese pharmaceutical company that manufactures AMITIZA for Sucampo and Sucampo's commercialization partners. It has a diverse pipeline of drug candidates in various stages of development in gastroenterology, ophthalmology, autoimmune, and inflammatory diseases and oncology and provides research and

development, manufacturing and marketing of drugs, development support, and contract manufacturing services.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AMITIZA

A medication developed for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

M&A Details

was acquired by

Sucampo Pharmaceuticals

on

obfuscation

. This deal was done in

Cash

.

Transaction Name

R-Tech Ueno acquired by Sucampo Pharmaceuticals

Acquired by

Sucampo Pharmaceuticals

Announced Date

obfuscation

Market Intelligence

People

View Profiles & Contacts

Headcount

Employee Profiles

Employee Profiles

Shuji Inoue Executive chairman
Yukiko Hashidera President & CEO
Yukihiko Majima Director and Senior Medical Director
Yoshiaki Yamana Executive Officer in Pharmaceuticals Division

News

Technology

View Tech Report

Active Website Tech Count

2

is actively using

2

technologies for its website, according to BuiltWith. These include

and

CommonCrawl Top 50m

.

Total IP

35

The intellectual property of

includes

registered patents primarily in the '

Medical Or Veterinary Science; Hygiene

' category, according to IPqwery.

Lists Featuring This Company

Lists Featuring This Company

Tokyo Medical Companies

1,143 Number of Organizations • $7.2B Total Funding Amount • 1,171 Number of Investors

Asia-Pacific (APAC) Pharmaceutical Female Founded Companies

197 Number of Organizations • $7.1B Total Funding Amount • 396 Number of Investors

Medical Acquired Companies With More Than 10 Employees

2,954 Number of Organizations • $148.4B Total Funding Amount • 4,532 Number of Investors

Tokyo Companies With More Than 10 Employees (Top 10K)

9,682 Number of Organizations • $166.5B Total Funding Amount • 16,007 Number of Investors

Sub-Organizations

Frequently Asked Questions

Where is

's headquarters?

is located in

Tokyo, Tokyo, Japan

.

Who are

's competitors? Alternatives and possible competitors to

may include

,

, and

Sandoz International

.